4893 items matching your search terms.

Pravastatin Reduces Total Mortality in Patients With Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effects in the LIPID Trial. The LIPID Study Group

Glasziou, P.; Mulray, S.; Hall, J.; Martin, A.; Harris, P.; Thompson, P.; Tonkin, A.; Simes, R.J.

Cost-effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels

Glasziou, PP; Mulray, SE; Hall, JP; Martin, A; Harris, P; Thompson, P; Tonkin, A; Simes, RJ

Costs, quality of life and cost-effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels. The LIPID Study Group

Glasziou, P.P.; Mulray, S.E.; Hall, J.P.; Martin, A.; Harris, P.; Thompson, P.; Tonkin, A.; Simes, R.J.

Cost effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels. The LIPID Study Group

Glasziou, P.P.; Mulray, S.E.; Hall, J.P.; Martin, A.; Harris, P.; Thompson, P.; Tonkin, A.; Simes, R.J.

Costs, quality of life and cost effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels. The LIPID Study Group

Glasziou, P.P.; Mulray, S.E.; Hall, J.P.; Martin, A.; Harris, P.; Thompson, P.; Tonkin, A.; Simes, R.J.

Hirudin reduces death and myocardial (re)infarction at 6 months: follow-up results of the GUSTO IIb Trial. The GUSTO IIb Investigators

Granger, C.B.; Van De Werf, F.; Armstrong, P.W.; Simes, J.; White, H.; MacAuley, C.M.; Califf, R.M.; Topol, E.

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation

Gurney, HP Ackland, S Gebski, V Farrell, G

Factors affecting epirubicin toxicity and pharmacokinetics - Evidence against using body surface area for dose calculation

Gurney, H. P. Ackland, S. Gebski, V. et al.

A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields

Harris, AW Basten, A Gebski, V Noonan, D Finnie, J Bath, ML Bangay, MJ Repacholi, MH

Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries

Hathaway, W. R. Peterson, E. D. Wagner, G. S. Granger, C. B. Zabel, K. M. Pieper, K. S. Clark, K. A. Woodlief, L. H. Califf, R. M.

Impact of cholesterol lowering treatment with pravastatin in women and elderly patients with coronary heart disease (CHD) and average cholesterol levels. The LIPID Study Group

Hunt, D.; Keech, A.C.; Thompson, A.; Baker, J.; Hague, W.; Aylward, P. A.; Sharpe, L.; Simes, J.; Tonkin, A.

Impact of cholesterol lowering treatment with pravastatin in women and elderly patients with coronary heart disease and average cholesterol levels

Hunt, D.; Keech, A.C.; Thomson, A.; Baker, J.; Hague, W.; Aylward, P.; Sharpe, N.; Simes, J.; Tonkin, A.

The role of the gallium scan in primary extranodal lymphoma

Hussain, R Christie, DR Gebski, V Barton, MB Gruenewald, SM

Data analysis and interpretation: statistical interpretation of data

Keech, A.

Considerations for overall clinical development: Design techniques to avoid bias

Keech, A.